Lancashire and South Cumbria
Formulary
 
back
9 Nutrition and blood

This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net. 

For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/

09-01-01-02 Parenteral iron

Prescribe parenteral iron products by brand name - important differences between formulations.


Ferric Carboxymaltose Ferinject®
Formulary

Injection 50mg/mL

First line choice
For use in patients with asthma or eczema
For use when total dose infusion is needed
Link  MHRA: Ferric carboxymaltose (Ferinject▼): risk of symptomatic hypophosphataemia leading to osteomalacia and fractures

Red View adult BNF  View SPC online  View childrens BNF
Ferric Derisomaltose Diafer®
Formulary

Injection 50mg/mL (2mL ampoule)

For use by renal unit only - preferred iron parenteral iron preparation for use by renal unit
Link  MHRA: Monofer 100mg/ml solution for injection/infusion▼ and Diafer 50mg/ml solution for injection▼: name change from iron isomaltoside to ferric derisomaltose

Red View adult BNF  View SPC online  View childrens BNF
Iron Sucrose Venofer®
Formulary

Injection 100mg/5mL

Second line after Ferinject

For intravenous use only

Do not use in patients with asthma or eczema

Red View adult BNF  View SPC online  View childrens BNF